
Osmond Resources narrowed its Orión scoping study release to Q3 CY26 as drilling at SOR-07/08 targets a maiden Mineral Resource Estimate. Plant design and product mix are substantially complete.
Osmond Resources (ASX: OSM) gave the market a firmer date for its Orión scoping study. Management now targets Q3 CY26 for release, narrowing the earlier 2H CY26 window. The study's plant design and expected product mix are substantially complete, the company said in a Thursday filing.
The update also confirmed drilling has started at SOR-07 and SOR-08. Those holes target extensions of a high-grade zone in Zone 1, not broad regional reconnaissance. Results will feed into a maiden Mineral Resource Estimate that underpins the scoping study.
Orión sits in Andalucía, southern Spain, across 232 square kilometres. Osmond expects to control an 80% interest in 95% of the project area once the scoping study is done. The project is a multi-stream critical minerals play, not a single-commodity story. Reported sample grades include 15.16% TiO2, 13.49% rutile, 5.57% ZrO2, and 1.18% TREO from Sample 1, plus 756ppm HfO2 and 1,431ppm La2O3 from AV-01.
Earlier scoping work set each processing plant module at 2Mtpa ROM and limited the initial study scope to concentrates production. That was meant to support a lower-capex development case. Metallurgical work on zircon and monazite recovery is running alongside drilling toward a JORC (2012) Mineral Resource Estimate. Downstream studies for mixed rare earth carbonate are planned, with a later study for NdPr oxide.
Osmond has a collaboration agreement with Técnicas Reunidas. Under it, Osmond would own a proposed MREC facility; Técnicas Reunidas would provide technology and EPC services. The parties said they would pursue Spanish and EU funding opportunities.
On the processing side, an earlier metallurgical update pointed to about 97.4% zircon liberation, a zircon concentrate grading about 50.2% ZrO2 at about 70% recovery, and monazite flotation results of about 19.4% TREO with about 76% recovery from a WHIMS stream. Titanium mineral processing results were still pending in that filing. Large-scale continuous beneficiation test work on a five-tonne bulk sample is also due to start.
On May 27, Osmond reported 15 additional outcrop channel samples across the Mineral Resource Estimate target area. Several intervals ran above 20% total heavy minerals, including 2.0m at 13.7% TiO2 and 29.1% THM from Z1-22, about 1.9m at 14.1% TiO2 and 29.1% THM from Z1-26, and 3.5m at 12.0% TiO2 and 24.9% THM from Z1-14. Independent consultants said those channel samples could be included in the estimation process.
The clearest near-term milestone is whether drilling at SOR-07 and SOR-08 delivers results strong enough to support the maiden JORC-compliant MRE the scoping study is expected to rely on. A second marker is whether the Q3 CY26 target holds, with timing still dependent on remaining technical inputs.
Osmond has not disclosed capex, opex, reserve numbers, or scoping-study economics in this update. The commercial case remains to be set out in a future release. Metallurgical follow-up is another checkpoint: titanium mineral processing results are still pending, and net monazite recoveries are not yet fully estimated.
The company flagged the likelihood of substantial additional financing. The Técnicas Reunidas collaboration is linked to targeted Spanish and EU funding, not confirmed support. Standard execution and approvals risks around timing remain, including drilling access and administrative steps referenced in prior filings. Osmond's control position is also conditional: the stated 80% interest in 95% of the project is tied to scoping study completion.
Osmond's Alpha Score sits at 46/100, a Mixed label in the Utilities sector. The stock page is at /stocks/so.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.